Negating Opioid and Pain Actively Through Intervention
| Status: | Completed |
|---|---|
| Conditions: | Chronic Pain, Chronic Pain, Chronic Pain |
| Therapuetic Areas: | Musculoskeletal |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/14/2019 |
| Start Date: | October 12, 2017 |
| End Date: | May 17, 2018 |
Chronic pain is one of the most prevalent and debilitating medical conditions and opioid
analgesics are a commonly prescribed class of medications in the United States. Opioid
efficacy has been proven in terms of managing acute and chronic pain; however, opioid
overdose deaths, addictions, and diversions have all continued to increase over the years.
The purpose of this study is to increase patient engagement in pain management and education,
and to decrease opioid use by 10% over the study period. This study will also help present
opportunities for future studies to obtain insight regarding the chronic use of opioids.
analgesics are a commonly prescribed class of medications in the United States. Opioid
efficacy has been proven in terms of managing acute and chronic pain; however, opioid
overdose deaths, addictions, and diversions have all continued to increase over the years.
The purpose of this study is to increase patient engagement in pain management and education,
and to decrease opioid use by 10% over the study period. This study will also help present
opportunities for future studies to obtain insight regarding the chronic use of opioids.
The institutional review board has approved this prospective single-center study at a large
900-bed academic university medical center. The electronic medical record system will
identify 300 patients, who are at least 18 years of age, with a history of opioid use for 3
or more months, or who are currently prescribed and are using long-acting or extended release
opioids. Procedures by student pharmacists, pharmacy residents, and pharmacists will include
reviewing medical records and prescription drug monitoring programs for the use of opioids,
evaluating baseline pain, quality of life, and satisfaction via questionnaires and assessment
questions, and performing thorough medication consultations on current opioid regimens.
Education of pain and promotion of adjunct and non-pharmacologic alternative therapies will
be completed to engage patients in assessing their pain and seeing the effectiveness of their
treatment. Patients will receive 3 follow-up interventions: 2 phone calls with a pharmacist
or student pharmacist at weeks 2 and 6, and a follow-up visit with a pain or primary care
physician. Opioid usage, pain, quality of life, and patient satisfaction will be assessed.
The primary outcome measured will be a decrease in opioid usage in morphine milligram
equivalents. Secondary outcomes include change in quality of life and patient satisfaction.
900-bed academic university medical center. The electronic medical record system will
identify 300 patients, who are at least 18 years of age, with a history of opioid use for 3
or more months, or who are currently prescribed and are using long-acting or extended release
opioids. Procedures by student pharmacists, pharmacy residents, and pharmacists will include
reviewing medical records and prescription drug monitoring programs for the use of opioids,
evaluating baseline pain, quality of life, and satisfaction via questionnaires and assessment
questions, and performing thorough medication consultations on current opioid regimens.
Education of pain and promotion of adjunct and non-pharmacologic alternative therapies will
be completed to engage patients in assessing their pain and seeing the effectiveness of their
treatment. Patients will receive 3 follow-up interventions: 2 phone calls with a pharmacist
or student pharmacist at weeks 2 and 6, and a follow-up visit with a pain or primary care
physician. Opioid usage, pain, quality of life, and patient satisfaction will be assessed.
The primary outcome measured will be a decrease in opioid usage in morphine milligram
equivalents. Secondary outcomes include change in quality of life and patient satisfaction.
Inclusion Criteria:
- at least 18 years of age
- history of opioid use for 3 or more months or
- currently prescribed and are using long-acting or extended release opioids
Exclusion Criteria:
- substance use
- oncology patients
- hematology patients
We found this trial at
1
site
Loma Linda University Loma Linda University (LLU) is a Seventh-day Adventist educational health-sciences institution with...
Click here to add this to my saved trials
